Cheng Du Sheng Nuo Biotec Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000051M8
CNY
23.04
-9.43 (-29.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
739.92
454.39
430.99
391.00
383.65
376.11
324.64
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
739.92
454.39
430.99
391.00
383.65
376.11
324.64
Raw Material Cost
331.92
203.57
164.84
142.76
111.52
81.61
66.86
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
46.37
39.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
17.70
12.01
9.33
3.56
0.27
0.12
0.79
Selling and Distribution Expenses
130.53
126.82
159.44
156.88
190.66
212.13
191.35
Other Expenses
3.29
3.48
1.80
1.93
1.29
-2.96
-2.96
Total Expenditure (Excl Depreciation)
513.00
377.15
351.61
322.49
315.33
310.61
268.71
Operating Profit (PBDIT) excl Other Income
226.9
77.2
79.4
68.5
68.3
65.5
55.9
Other Income
-2.95
9.08
16.23
13.72
5.55
11.46
9.48
Operating Profit (PBDIT)
264.30
110.22
121.44
103.79
89.51
86.56
71.56
Interest
17.70
12.01
9.33
3.56
0.27
0.12
0.79
Exceptional Items
0.25
0.34
0.32
0.00
0.00
-0.27
-1.17
Gross Profit (PBDT)
408.00
250.82
266.15
248.24
272.13
294.50
257.79
Depreciation
57.73
35.60
29.14
25.95
18.75
17.29
13.29
Profit Before Tax
189.12
62.95
83.29
74.27
70.49
68.88
56.32
Tax
31.24
11.67
9.80
7.88
9.24
8.88
8.18
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
157.92
50.02
70.34
64.48
61.25
60.00
48.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
157.92
50.02
70.34
64.48
61.25
60.00
48.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.03
-0.19
-0.01
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
157.89
49.84
70.32
64.48
61.25
60.00
48.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,057.60
918.34
879.93
826.74
785.14
437.57
376.46
Earnings per share (EPS)
0.72
0.23
0.32
0.29
0.28
0.27
0.22
Diluted Earnings per share
0.72
0.23
0.32
0.29
0.28
0.27
0.22
Operating Profit Margin (Excl OI)
28.32%
14.42%
17.65%
16.4%
17.0%
15.37%
15.03%
Gross Profit Margin
33.36%
21.69%
26.09%
25.63%
23.26%
22.91%
21.44%
PAT Margin
21.34%
11.01%
16.32%
16.49%
15.97%
15.95%
14.83%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 62.83% vs 5.43% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 217.07% vs -29.16% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 164.39% vs -3.90% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 47.50% vs 29.03% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Cheng Du Sheng Nuo Biotec Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
739.92
0
739.92
Other Operating Income
0.00
0.00
0.00
Total Operating income
739.92
0
739.92
Raw Material Cost
331.92
0
331.92
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
17.70
0
17.70
Selling and Distribution Expenses
130.53
0
130.53
Other Expenses
3.29
0.00
3.29
Total Expenditure (Excl Depreciation)
513.00
0
513.00
Operating Profit (PBDIT) excl Other Income
226.92
0.00
226.92
Other Income
-2.95
0
-2.95
Operating Profit (PBDIT)
264.30
0
264.30
Interest
17.70
0
17.70
Exceptional Items
0.25
0
0.25
Gross Profit (PBDT)
408.00
0
408.00
Depreciation
57.73
0
57.73
Profit Before Tax
189.12
0
189.12
Tax
31.24
0
31.24
Provisions and contingencies
0
0
0.00
Profit After Tax
157.92
0
157.92
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
157.92
0
157.92
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.03
0
-0.03
Other related items
0.00
0.00
0.00
Consolidated Net Profit
157.89
0
157.89
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,057.60
0
1,057.60
Earnings per share (EPS)
0.72
0
0.72
Diluted Earnings per share
0.72
0
0.72
Operating Profit Margin (Excl OI)
28.32%
0%
0.00
28.32%
Gross Profit Margin
33.36%
0%
0.00
33.36%
PAT Margin
21.34%
0%
0.00
21.34%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 73.99 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 62.83% vs 5.43% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 15.79 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 217.07% vs -29.16% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.73 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 164.39% vs -3.90% in Dec 2024

Annual - Interest
Interest 1.77 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 47.50% vs 29.03% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.32%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024